Roles
Associate Professor of Clinical Medicine
Chief, Leukemia Section
-
Biography
Justin M. Watts, M.D., is an Associate Professor of Clinical Medicine in the Division of Hematology at the University of Miami Miller School of Medicine. He serves as Chief of the Leukemia Section and holds the Pap Corps Endowed Professorship in Leukemia.Dr. Watts earned his medical degree from Emory University School of Medicine in 2007 and completed his residency in Internal Medicine at the University of California, San Francisco, in 2010. He subsequently completed fellowships in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center in 2014.
At the Sylvester Comprehensive Cancer Center, Dr. Watts leads a clinical and translational research program focused on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN). His research is dedicated to developing safer, more effective therapies, including epigenetic-targeted treatments and precision medicine approaches.
Dr. Watts has played a key role in advancing early-phase clinical trials, with over 240 patients treated through his studies. His work has contributed to the development of novel therapies, including the IDH1 inhibitor olutasidenib, which is FDA-approved for relapsed or refractory AML.
His dedication to improving leukemia care is reflected in numerous grants and awards, including funding from the National Institutes of Health, and his efforts continue to advance both patient care and scientific discovery. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
No result found
-
Research Interests
Dr. Watts’ research focuses on generating new therapeutic options for patients with acute myeloid leukemia and myelodysplastic syndrome. He does this through translational research with laboratory investigators and by designing and conducting early phase clinical trials of novel agents and precision medicine approaches, and by analyzing patients cells in the lab to understand the mechanisms of action. His research specifically focuses on developing epigenetic-targeted therapies for these diseases. -
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.
-
Professional Activities
No result found